No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use*
-
CA-125 Antigen / blood
-
Carcinoma / classification
-
Carcinoma / diagnosis*
-
Carcinoma / pathology
-
Europe / epidemiology
-
Female
-
Follow-Up Studies
-
Humans
-
Incidence
-
Membrane Proteins / blood
-
Meta-Analysis as Topic
-
Neoplasm Staging
-
Neoplasms, Glandular and Epithelial / drug therapy*
-
Ovarian Neoplasms / diagnosis*
-
Ovarian Neoplasms / pathology
-
Ovarian Neoplasms / therapy*
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Secondary Prevention
-
Treatment Outcome
Substances
-
Antineoplastic Agents
-
CA-125 Antigen
-
MUC16 protein, human
-
Membrane Proteins